Company Information

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE455.45-0.2 (-0.04 %)
PREV CLOSE ( ) 455.65
OPEN PRICE ( ) 476.95
BID PRICE (QTY) 452.60 (1)
OFFER PRICE (QTY) 455.35 (6)
VOLUME 1207
TODAY'S LOW / HIGH ( )444.90 476.95
52 WK LOW / HIGH ( )361.2 621.4
NSE453.00-2.8 (-0.61 %)
PREV CLOSE( ) 455.80
OPEN PRICE ( ) 460.05
BID PRICE (QTY) 452.10 (1)
OFFER PRICE (QTY) 453.30 (1)
VOLUME 17278
TODAY'S LOW / HIGH( ) 442.20 461.45
52 WK LOW / HIGH ( )362 623.15
ChairmanSivalinga Prasad Vasireddi
Managing DirectorHarita Vasireddi
Company SecretarySujani Vasireddi
Executive DirectorSatya Sreenivas Neerukonda
Executive Director - OperationsHarriman Vungal
Non Executive Independent DirectorSanjay Dave
Yadagiri R Pendri
Yalamanchili Prameela Rani
G Purnachandra Rao
Incorporation Year : 16-11 1990

Registered Office :

Address : Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R District Hyderabad,
Telangana-500051 .

Phone : 040- 27264141

Email :  shares@vimta.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.